[Lung cancer in Japan: analysis of lung cancer registry cases resected in 2004].

Noriyoshi Sawabata, Yoshitaka Fujii, Hisao Asamura, Hiroaki Nomori, Yoichi Nakanishi, Kenji Eguchi, Masaki Mori, Meinoshin Okumura, Etsuo Miyaoka, Kohei Yokoi, Joint Committee for Lung Cancer Registration Japanese Joint Committee for Lung Cancer Registration

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Japan Lung Cancer Society, Japanese Association for Chest Surgery, and Japanese Respiratory Society jointly established the Japanese Joint Committee for Lung Cancer Registration. In 2010, analyses of 11,663 cases of lung cancer that underwent surgical resection in 2004 were performed, then the findings were registered and collected for analysis by the committee. The survival rate for all cases was 69.6%, while the 5-year survival rate in males (n = 7.369) was 63.0% and 80.9% in females (n = 4,294). The 5-year survival rates by c-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 6,295, 6,295), 82.0% and 82.0%; IB (n = 2,788, 2,339), 63.4% and 66.1%, IIA (n = 203, 819), 55.4% and 54.5%; IIB (n = 899, 648), 48.6% and 46.4%: IIIA (n = 940, 1,216), 43.3% and 42.8%; IIIB (n = 407, 90), 41.6% and 40.3% and IV (n = 131, 256), 29.1% and 31.4%, respectively. The 5-year survival rates by p-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 5,611, 4,978), 85.9% and 86.8%; IB (n = 2,398, 2,552), 69.3% and 73.9%; IIA (n = 336, 941), 60.9% and 61.6%; IIB (n = 977, 848), 51.1% and 49.8%; IIIA (n = 1354, 1804), 41.0% and 40.9%; IIIB (n = 799, 106), 36.7% and 27.8%, and IV (n = 188, 434), 27.8% and 27.9%, respectively. The 5-year survival rates by histological type were as follow: adenocarcinoma, 74.9% squamous cell carcinoma, 59.1%; large cell carcinoma, 53.3% small cell carcinoma, 52.6%; and adenosquamous cell carcinoma, 50.8%. Operative death occurred in 48 cases (0.4%) and hospital death in 46 (0.4%).

Original languageEnglish
Pages (from-to)327-342
Number of pages16
JournalNihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
Volume49
Issue number4
Publication statusPublished - Apr 1 2011

Fingerprint

Registries
Lung Neoplasms
Japan
Adenosquamous Carcinoma
Large Cell Carcinoma
Small Cell Carcinoma
Squamous Cell Carcinoma
Adenocarcinoma
Thorax

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Sawabata, N., Fujii, Y., Asamura, H., Nomori, H., Nakanishi, Y., Eguchi, K., ... Japanese Joint Committee for Lung Cancer Registration, J. C. F. L. C. R. (2011). [Lung cancer in Japan: analysis of lung cancer registry cases resected in 2004]. Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society, 49(4), 327-342.

[Lung cancer in Japan : analysis of lung cancer registry cases resected in 2004]. / Sawabata, Noriyoshi; Fujii, Yoshitaka; Asamura, Hisao; Nomori, Hiroaki; Nakanishi, Yoichi; Eguchi, Kenji; Mori, Masaki; Okumura, Meinoshin; Miyaoka, Etsuo; Yokoi, Kohei; Japanese Joint Committee for Lung Cancer Registration, Joint Committee for Lung Cancer Registration.

In: Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society, Vol. 49, No. 4, 01.04.2011, p. 327-342.

Research output: Contribution to journalArticle

Sawabata, N, Fujii, Y, Asamura, H, Nomori, H, Nakanishi, Y, Eguchi, K, Mori, M, Okumura, M, Miyaoka, E, Yokoi, K & Japanese Joint Committee for Lung Cancer Registration, JCFLCR 2011, '[Lung cancer in Japan: analysis of lung cancer registry cases resected in 2004].', Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society, vol. 49, no. 4, pp. 327-342.
Sawabata, Noriyoshi ; Fujii, Yoshitaka ; Asamura, Hisao ; Nomori, Hiroaki ; Nakanishi, Yoichi ; Eguchi, Kenji ; Mori, Masaki ; Okumura, Meinoshin ; Miyaoka, Etsuo ; Yokoi, Kohei ; Japanese Joint Committee for Lung Cancer Registration, Joint Committee for Lung Cancer Registration. / [Lung cancer in Japan : analysis of lung cancer registry cases resected in 2004]. In: Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society. 2011 ; Vol. 49, No. 4. pp. 327-342.
@article{731626b8cb6b42f6a16c8369303999a0,
title = "[Lung cancer in Japan: analysis of lung cancer registry cases resected in 2004].",
abstract = "The Japan Lung Cancer Society, Japanese Association for Chest Surgery, and Japanese Respiratory Society jointly established the Japanese Joint Committee for Lung Cancer Registration. In 2010, analyses of 11,663 cases of lung cancer that underwent surgical resection in 2004 were performed, then the findings were registered and collected for analysis by the committee. The survival rate for all cases was 69.6{\%}, while the 5-year survival rate in males (n = 7.369) was 63.0{\%} and 80.9{\%} in females (n = 4,294). The 5-year survival rates by c-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 6,295, 6,295), 82.0{\%} and 82.0{\%}; IB (n = 2,788, 2,339), 63.4{\%} and 66.1{\%}, IIA (n = 203, 819), 55.4{\%} and 54.5{\%}; IIB (n = 899, 648), 48.6{\%} and 46.4{\%}: IIIA (n = 940, 1,216), 43.3{\%} and 42.8{\%}; IIIB (n = 407, 90), 41.6{\%} and 40.3{\%} and IV (n = 131, 256), 29.1{\%} and 31.4{\%}, respectively. The 5-year survival rates by p-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 5,611, 4,978), 85.9{\%} and 86.8{\%}; IB (n = 2,398, 2,552), 69.3{\%} and 73.9{\%}; IIA (n = 336, 941), 60.9{\%} and 61.6{\%}; IIB (n = 977, 848), 51.1{\%} and 49.8{\%}; IIIA (n = 1354, 1804), 41.0{\%} and 40.9{\%}; IIIB (n = 799, 106), 36.7{\%} and 27.8{\%}, and IV (n = 188, 434), 27.8{\%} and 27.9{\%}, respectively. The 5-year survival rates by histological type were as follow: adenocarcinoma, 74.9{\%} squamous cell carcinoma, 59.1{\%}; large cell carcinoma, 53.3{\%} small cell carcinoma, 52.6{\%}; and adenosquamous cell carcinoma, 50.8{\%}. Operative death occurred in 48 cases (0.4{\%}) and hospital death in 46 (0.4{\%}).",
author = "Noriyoshi Sawabata and Yoshitaka Fujii and Hisao Asamura and Hiroaki Nomori and Yoichi Nakanishi and Kenji Eguchi and Masaki Mori and Meinoshin Okumura and Etsuo Miyaoka and Kohei Yokoi and {Japanese Joint Committee for Lung Cancer Registration}, {Joint Committee for Lung Cancer Registration}",
year = "2011",
month = "4",
day = "1",
language = "English",
volume = "49",
pages = "327--342",
journal = "Respiratory Investigation",
issn = "2212-5345",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - [Lung cancer in Japan

T2 - analysis of lung cancer registry cases resected in 2004].

AU - Sawabata, Noriyoshi

AU - Fujii, Yoshitaka

AU - Asamura, Hisao

AU - Nomori, Hiroaki

AU - Nakanishi, Yoichi

AU - Eguchi, Kenji

AU - Mori, Masaki

AU - Okumura, Meinoshin

AU - Miyaoka, Etsuo

AU - Yokoi, Kohei

AU - Japanese Joint Committee for Lung Cancer Registration, Joint Committee for Lung Cancer Registration

PY - 2011/4/1

Y1 - 2011/4/1

N2 - The Japan Lung Cancer Society, Japanese Association for Chest Surgery, and Japanese Respiratory Society jointly established the Japanese Joint Committee for Lung Cancer Registration. In 2010, analyses of 11,663 cases of lung cancer that underwent surgical resection in 2004 were performed, then the findings were registered and collected for analysis by the committee. The survival rate for all cases was 69.6%, while the 5-year survival rate in males (n = 7.369) was 63.0% and 80.9% in females (n = 4,294). The 5-year survival rates by c-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 6,295, 6,295), 82.0% and 82.0%; IB (n = 2,788, 2,339), 63.4% and 66.1%, IIA (n = 203, 819), 55.4% and 54.5%; IIB (n = 899, 648), 48.6% and 46.4%: IIIA (n = 940, 1,216), 43.3% and 42.8%; IIIB (n = 407, 90), 41.6% and 40.3% and IV (n = 131, 256), 29.1% and 31.4%, respectively. The 5-year survival rates by p-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 5,611, 4,978), 85.9% and 86.8%; IB (n = 2,398, 2,552), 69.3% and 73.9%; IIA (n = 336, 941), 60.9% and 61.6%; IIB (n = 977, 848), 51.1% and 49.8%; IIIA (n = 1354, 1804), 41.0% and 40.9%; IIIB (n = 799, 106), 36.7% and 27.8%, and IV (n = 188, 434), 27.8% and 27.9%, respectively. The 5-year survival rates by histological type were as follow: adenocarcinoma, 74.9% squamous cell carcinoma, 59.1%; large cell carcinoma, 53.3% small cell carcinoma, 52.6%; and adenosquamous cell carcinoma, 50.8%. Operative death occurred in 48 cases (0.4%) and hospital death in 46 (0.4%).

AB - The Japan Lung Cancer Society, Japanese Association for Chest Surgery, and Japanese Respiratory Society jointly established the Japanese Joint Committee for Lung Cancer Registration. In 2010, analyses of 11,663 cases of lung cancer that underwent surgical resection in 2004 were performed, then the findings were registered and collected for analysis by the committee. The survival rate for all cases was 69.6%, while the 5-year survival rate in males (n = 7.369) was 63.0% and 80.9% in females (n = 4,294). The 5-year survival rates by c-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 6,295, 6,295), 82.0% and 82.0%; IB (n = 2,788, 2,339), 63.4% and 66.1%, IIA (n = 203, 819), 55.4% and 54.5%; IIB (n = 899, 648), 48.6% and 46.4%: IIIA (n = 940, 1,216), 43.3% and 42.8%; IIIB (n = 407, 90), 41.6% and 40.3% and IV (n = 131, 256), 29.1% and 31.4%, respectively. The 5-year survival rates by p-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 5,611, 4,978), 85.9% and 86.8%; IB (n = 2,398, 2,552), 69.3% and 73.9%; IIA (n = 336, 941), 60.9% and 61.6%; IIB (n = 977, 848), 51.1% and 49.8%; IIIA (n = 1354, 1804), 41.0% and 40.9%; IIIB (n = 799, 106), 36.7% and 27.8%, and IV (n = 188, 434), 27.8% and 27.9%, respectively. The 5-year survival rates by histological type were as follow: adenocarcinoma, 74.9% squamous cell carcinoma, 59.1%; large cell carcinoma, 53.3% small cell carcinoma, 52.6%; and adenosquamous cell carcinoma, 50.8%. Operative death occurred in 48 cases (0.4%) and hospital death in 46 (0.4%).

UR - http://www.scopus.com/inward/record.url?scp=79959581246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959581246&partnerID=8YFLogxK

M3 - Article

C2 - 21591465

AN - SCOPUS:79959581246

VL - 49

SP - 327

EP - 342

JO - Respiratory Investigation

JF - Respiratory Investigation

SN - 2212-5345

IS - 4

ER -